Recurrent non-hodgkin lymphoma Clinical Trials

Delta Trials indexes 47 clinical trials for Recurrent non-hodgkin lymphoma in its publicly accessible dataset. Of these, 5 enrolling participants at this time and 22 trials have reached completion. This research takes place spanning 150 research sites around the world. An additional 20 trials are in preparatory or other active non-recruiting stages. Since 2020, 6 trials were terminated, illustrating the dynamic nature of clinical research. Delta Trials updates this record as new data becomes available from ClinicalTrials.gov, providing a versioned view of how research activity has changed over time.